A combination of immunotherapy treatments may improve survival rate and lower the risk of life-threatening events in patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, a study has found.
Cutaneous melanoma is an aggressive and deadly form of skin cancer.
In its early stages, melanoma is often cured with surgery alone. However, most patients who are diagnosed in the late stages of the disease cannot undergo surgery, thus drug therapy remains the only course of treatment.
ᐧ
Comments